We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
The Tycoon Herald
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Reading: Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com
Sign In
The Tycoon HeraldThe Tycoon Herald
Font ResizerAa
Search
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© Tycoon Herald. All Rights Reserved.
Ventyx Biosciences’ chief scientific officer sells ,682 in inventory By Investing.com
The Tycoon Herald > Business > Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com
Business

Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com

Tycoon Herald
By Tycoon Herald 3 Min Read
Share
SHARE

Ventyx Biosciences’ chief scientific officer sells $29,682 in inventory By Investing.com

John Nuss, the Chief Scientific Officer of Ventyx Biosciences, Inc. (NASDAQ:VTYX), not too long ago bought shares of the corporate’s frequent inventory. In line with a current submitting with the Securities and Change Fee, Nuss bought 13,161 shares on December 19, 2024, at a mean worth of $2.2553 per share, totaling roughly $29,682. The transaction occurred close to the inventory’s 52-week low of $1.67, with shares at the moment buying and selling at $2.28. InvestingPro evaluation signifies the inventory is at the moment undervalued, with analysts setting worth targets starting from $2 to $21.

This transaction was carried out as a broker-assisted sale to cowl tax obligations associated to the vesting of restricted inventory models. Following this sale, Nuss holds 485,701 shares of Ventyx Biosciences.

Moreover, on December 17, 2024, Nuss acquired 34,930 shares of frequent inventory by means of the vesting of restricted inventory models, with no money exchanged on this transaction.

In different current information, Ventyx Biosciences has introduced a number of key developments. The corporate introduced encouraging long-term efficacy knowledge from its Part 2 examine of tamuzimod, a therapy for ulcerative colitis, on the United European Gastroenterology Week Convention. The examine achieved its major endpoint of scientific remission, with elevated remission charges noticed for each 30 mg and 60 mg doses. Regardless of these optimistic outcomes, Ventyx Biosciences doesn’t plan to advance tamuzimod into Part 3 trials with no associate.

As well as, the corporate has acquired a $27 million funding from pharmaceutical large Sanofi (NASDAQ:), linked to Ventyx’s drug candidate for Parkinson’s illness and weight problems, VTX3232. This funding is anticipated to increase the corporate’s monetary runway into the second half of 2026. Nevertheless, the corporate’s Part 2 trial of one other drug, VTX958, didn’t meet its major objective in treating Crohn’s illness, and Ventyx has indicated it is not going to conduct additional trials of VTX958 with its inside sources.

Analysts at H.C. Wainwright have maintained a Impartial score for Ventyx Biosciences, whereas Piper Sandler has saved its Chubby score and Oppenheimer has retained an Outperform score regardless of a lowered worth goal. Lastly, Ventyx Biosciences reported a web quarterly lack of $38.6 million, with money, money equivalents, and marketable securities totaling $279.7 million.

This text was generated with the assist of AI and reviewed by an editor. For extra data see our T&C.

You Might Also Like

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds

Fashion Designer Hyeonseo Irene Park: Redefining Menswear Through Originality and Collaboration

From Pattaya to the World: Bryan Flowers’ Unstoppable Rise as a Global Entrepreneur

Astana International Forum 2025: “Connecting Minds, Shaping the Future”

Investment success: GP Fatih Marketing Research Co LLC and the gold dream in Africa

TAGGED:BioscienceschiefInvesting.comofficerScientificsellsstockVentyx
Share This Article
Facebook Twitter Email Copy Link Print
Sofia Vergara Sizzling Photographs to Kick Off Her 53rd Bday!
Entertainment

Sofia Vergara Sizzling Photographs to Kick Off Her 53rd Bday!

Sofia Vergara Sizzling Photographs To Kick Off Her 53rd Birthday! Printed July 10, 2025 12:01 AM PDT One other scorching summer season day, and one other horny star celebrating their…

By Tycoon Herald 1 Min Read
Indonesia says EU deforestation legislation continues to be unworkable
July 10, 2025
U.S. points sanctions in opposition to United Nations investigator probing abuses in Gaza
July 10, 2025
At present on Sky Sports activities Racing: Doncaster and Newbury host dwell Thursday motion
July 10, 2025
Megan Thee Stallion Flaunts Main Underboob in Inexperienced Bikini
July 10, 2025

You Might Also Like

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters
Business

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters

By Tycoon Herald 6 Min Read
Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com
Business

Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com

By Tycoon Herald 5 Min Read
EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com
Business

EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com

By Tycoon Herald 4 Min Read

More Popular from Tycoon Herald

MEET THE FATHER OF COADUNATE ECONOMIC MODEL
BusinessTrending

MEET THE FATHER OF COADUNATE ECONOMIC MODEL

By Tycoon Herald 2 Min Read
Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

By Tycoon Herald
Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments
InnovationTrending

Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments

By Tycoon Herald 7 Min Read
Sports

Novak Djokovic beats Jakub Mensik at Shanghai Masters to arrange semi-final assembly with Taylor Fritz

Novak Djokovic got here from a set right down to beat Jakub Mensik for a spot…

By Tycoon Herald
Business

Italy’s antitrust investigates Armani, Dior over alleged exploitation of employees By Reuters

(Reuters) - Italy's competitors authority (AGCM) mentioned on Wednesday it had began an investigation into luxurious…

By Tycoon Herald
Trending

U.S. Blew Up a C.I.A. Post Used to Evacuate At-Risk Afghans

A controlled detonation by American forces that was heard throughout Kabul has destroyed Eagle Base, the…

By Tycoon Herald
Leadership

Northern Lights: 17 Best Places To See Them In 2021

Who doesn’t dream of seeing the northern lights? According to a new survey conducted by Hilton, 59% of Americans…

By Tycoon Herald
Real Estate

Exploring Bigfork, Montana: A Little Town On A Big Pond

Bigfork, Montana, offers picturesque paradise in the northern wilderness. National Parks Realty With the melting of…

By Tycoon Herald
Leadership

Leaders Need To Know Character Could Be Vital For Corporate Culture

Disney's unique culture encourages young employees to turn up for work with smiles on their faces.…

By Tycoon Herald
The Tycoon Herald

Tycoon Herald: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Terms of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© Tycoon Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?